LONGEVA.
··

CJC-1295 with DAC

CJC-1295 with DAC (GHRH analogue)

Share
TelegramWhatsAppViber
For research use only
This product is sold as a reagent for laboratory research and is not intended for administration to humans or animals.
Delivery
International delivery: 7–21 days depending on the country. We confirm the cost after checkout.
Payment
Cryptocurrency (USDT, BTC, ETH) or a Visa / Mastercard card (3-D Secure). Learn more →
Quality guarantee
Every batch is independently lab-tested. For research use only.

About

CJC-1295 with DAC is a synthetic growth-hormone-releasing-hormone (GHRH) analogue built on the GRF(1-29) fragment. Four amino-acid substitutions protect the molecule from DPP-4 cleavage, while the DAC (Drug Affinity Complex, a maleimide group) binds covalently to plasma albumin — the distinction from CJC-1295 without DAC, and what extends the half-life from minutes to days in research models.

Studied for raising baseline GH and IGF-1 while preserving the pulsatile character of secretion. It acts through the GHRH receptor — a pathway distinct from secretagogues such as GHRP-6.

Supplied as a lyophilized powder; every batch is assayed by HPLC.

For laboratory research use only. Not for human or veterinary use.

Specifications

Active substanceCJC-1295 with DAC (GHRH analogue)
Formlyophilized powder

Dosing

Reference data — not a recommendation
The information below is provided from public sources for reference only. It is not advice or instructions for use; products are intended for laboratory research only and not for human consumption.

A healthy-adult study examined single subcutaneous doses of 30–250 μg/kg and separate multiple-dose cohorts.

Full dosing guideTitration schedule · reference

Reviews

No reviews yet

Bought this product? Be the first to tell others — it takes a minute.

Related products